SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SkinHealth Systems Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.55−0.01 (-0.09%)
Close on Oct 19, 2026
- Market cap
- $1.37B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$18.05 (−63.11%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
SkinHealth Systems Inc. saw revenue fall 6.5% to $290.05M over the twelve months to Jun 30, 2026. Free cash flow was $21.14M, down 46.1% from a year earlier.
Revenue
$290.05M
-6.5% vs. a year earlier
Operating income
-$4.31M
TTM Q2 2026
Free cash flow
$21.14M
-46.1% vs. a year earlier
EPS, diluted
-$0.22
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.37B
- P/E ratio
- –
- Price to sales
- 4.71
- Price to book
- 24.60
- Dividend yield
- –
- Free cash flow yield
- 1.55%
Fundamentals
- Revenue
- $290.05M
- Net income
- -$28.43M
- EPS, diluted
- -$0.22
- Free cash flow
- $21.14M
- Book value per share
- $0.43
- Diluted shares
- 130M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$290.05M-6.5% YoY
Gross profit
$192.45M+0.9% YoY
Operating income
-$4.31M
Net income
-$28.43M
EPS, diluted
-$0.22
Free cash flow
$21.14M-46.1% YoY
Reported periodTrailing twelve months